Analysts foresee less revenue Biogen

Tomorrow the American Biogen will report its past quarters results. Over the current book year the total revenue will be 13,81 billion USD (consensus estimates). This is slightly lower than 2019's revenue of 14,38 billion USD.

Historical revenues and results Biogen plus estimates 2020

The analysts expect for 2020 a net profit of 5,64 billion USD. According to most of the analysts the company will have a profit per share for this book year of 34,68 USD. The price/earnings-ratio is then 8,07.

Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a limited 0,31 percent.

Biogen's market capitalization is around 55,22 billion USD. The Biogen stock was the past 12 months quite unstable. Since last October the stock is even 27 percent higher. This year the stock price moved between 220 and 375 dollar.

Historical stock prices Biogen from 2007 till 2020

Click here for dividend Biogen. On Monday the stock closed at 280,01 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.